Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -134.48% is in line with its 5-year average of -144.84%, around the middle of its 5-year range (-279.77%–0.00%).
2.60% above its 12-month average of -138.07%.
Reported quarterly operating margin; no daily interpolation. Q1 FY2027 (2026-07-31): -121.59%.
OPERATING MARGIN
-134.48%
OPERATING MARGIN AVG TTM
-138.07%
OPERATING MARGIN AVG 3Y
-165.85%
OPERATING MARGIN AVG 5Y
-144.84%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+2.60%
CURRENT VS 3Y AVG
+18.91%
CURRENT VS 5Y AVG
+7.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 595 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Kestra Medical Technologies, Ltd.
Market Cap
$1.63B
Operating Margin
-134.48%
TTM Avg
-138.07%
3Y Avg
-165.85%
5Y Avg
-144.84%
Market Cap
$1.63B
Operating Margin
-5.55%
TTM Avg
-16.51%
3Y Avg
-27.71%
5Y Avg
-34.02%
Market Cap
$1.61B
Operating Margin
15.35%
TTM Avg
4.65%
3Y Avg
1.95%
5Y Avg
-3.05%
Market Cap
$1.73B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$1.73B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.72B
Operating Margin
1.20%
TTM Avg
-1.69%
3Y Avg
-4.84%
5Y Avg
-5.86%
Market Cap
$1.53B
Operating Margin
36.66%
TTM Avg
42.52%
3Y Avg
46.05%
5Y Avg
62.54%
Market Cap
$1.53B
Operating Margin
31.49%
TTM Avg
29.35%
3Y Avg
-34.88%
5Y Avg
-5.38%
Market Cap
$1.74B
Operating Margin
-737.04%
TTM Avg
-849.82%
3Y Avg
-849.82%
5Y Avg
-849.82%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kestra Medical Technologies, Ltd. (KMTS) | $1.63B | -134.48% | -138.07% | -165.85% | -144.84% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.63B | -5.55% | -16.51% | -27.71% | -34.02% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.61B | 15.35% | 4.65% | 1.95% | -3.05% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.73B | -651.67% | -787.38% | -968.58% | -820.03% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 11.69% | -8.16% | -10.59% | -4.68% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.72B | 1.20% | -1.69% | -4.84% | -5.86% |
| Innoviva, Inc. (INVA)vs › | $1.53B | 36.66% | 42.52% | 46.05% | 62.54% |
| Nutex Health, Inc. (NUTX)vs › | $1.53B | 31.49% | 29.35% | -34.88% | -5.38% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.74B | -737.04% | -849.82% | -849.82% | -849.82% |
| Certara, Inc. (CERT)vs › | $1.50B | 1.86% | 2.28% | 0.69% | -0.42% |
Gross Margin
53.9%
Operating Margin
-134.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-07-31 | -121.59% |
| 2026-04-30 | -137.38% |
| 2026-01-31 | -141.59% |
| 2025-10-31 | -140.73% |
| 2025-07-31 | -149.08% |
| 2025-04-30 | -279.77% |
| 2025-01-31 | -136.52% |
| 2024-10-31 | -130.07% |
| 2024-07-31 | -144.19% |
| 2024-04-30 | -202.40% |
| 2024-01-31 | -240.98% |
| 2021-07-31 | 0.00% |
